A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
NCT05035732 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-01-18
Summary
To perform both PET scans and MRIs in the same setting using a simultaneous PET/MRI scanner.
Conditions
- Prostate Cancer
- Prostate Nodule
Interventions
- RADIATION
-
18F-fluciclovine
IV
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Devaki S Surasi · M.D. Anderson Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-25
- Primary Completion
- 2024-01-17
- Completion
- 2024-01-17
More Related Trials
-
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
NCT04134208 ·Status: TERMINATED ·Phase: PHASE4
-
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
NCT06706921 ·Status: RECRUITING ·Phase: PHASE4
-
11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
NCT02397408 ·Status: COMPLETED ·Phase: PHASE2
-
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
NCT04158245 ·Status: COMPLETED ·Phase: PHASE2
-
18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
NCT03930173 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
NCT05554302 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FLUC PET/MR in Patients With Brain Mets
NCT06159335 ·Status: RECRUITING ·Phase: PHASE3
-
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone
NCT03707184 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
NCT02809690 ·Status: TERMINATED ·Phase: PHASE1
-
FLT PET Imaging for Cervical Cancer
NCT01075412 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma
NCT04114370 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
NCT05722925 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
NCT04689048 ·Status: RECRUITING ·Phase: PHASE1
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
NCT01176500 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
FTT PET/CT in Metastatic Prostate Cancer
NCT05242744 ·Status: RECRUITING
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
NCT01993160 ·Status: COMPLETED ·Phase: NA
-
Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease
NCT04765423 ·Status: WITHDRAWN ·Phase: NA
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
NCT06048094 ·Status: RECRUITING ·Phase: PHASE1
-
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
NCT01717391 ·Status: COMPLETED ·Phase: PHASE2
-
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer
NCT04340765 ·Status: COMPLETED ·Phase: NA
-
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
NCT03496844 ·Status: COMPLETED ·Phase: NA
-
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
NCT02443571 ·Status: COMPLETED
-
Pilot Study of 18F-FLT PET
NCT00585741 ·Status: TERMINATED ·Phase: NA